Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

© 2013 American Society for Bone and Mineral Research. All rights reserved. This chapter focuses on the genetics of renal stones and in particular those associated with hypercalciuric renal stone disease (nephrolithiasis) in man. The greatest risk factor for nephrolithiasis, after controlling for known dietary determinants, is having an affected family member. Families with idiopathic hypercalciuria (IH) and recurrent calcium oxalate stones usually reveal an autosomal dominant mode of inheritance. Patients with autosomal dominant hypocalcaemia with hypercalciuria (ADHH) usually have mild hypocalcaemia that is generally asymptomatic but may in some patients be associated with carpopedal spasm and seizures. Studies of monogenic forms of hypercalciuric nephrolithiasis, e.g., Bartter syndrome, Dent's disease, autosomal dominant hypocalcemic hypercalciuria, hypercalciuric nephrolithiasis with hypophosphatemia, and familial hypomagnesemia with hypercalciuria have helped to identify a number of transporters, channels, and receptors that are involved in regulating the renal tubular reabsorption of calcium.

Original publication





Book title

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition

Publication Date



884 - 891